#-featured-posts-43-107{oxy-featured-posts-card1-image:https://lunit.io/en/wp-content/uploads/2025/09/Breast-Tomosynthesis-AI-Solution.jpg;oxy-featured-posts-card1-title:Lunit Meets MDR CE Standards for 3D Breast Tomosynthesis AI Solution;oxy-featured-posts-card1-date:May 20,2023;oxy-featured-posts-card2-title:Lunit to Supply AI Platform to Australia’s BreastScreen NSW Machine Reading Project;oxy-featured-posts-card2-date:Nov 16,2022;oxy-featured-posts-card2-category:#;oxy-featured-posts-card2-image:https://lunit.io/en/wp-content/uploads/2025/09/dbt-bsnsw-2.634b177.jpg;oxy-featured-posts-card1-category:#;oxy-featured-posts-card1-url:https://www.lunit.io/en/company/news/lunit-meets-mdr-ce-standards-for-3d-breast-tomosynthesis-ai-solution;oxy-featured-posts-card1-target:yes;oxy-featured-posts-card2-url:https://www.lunit.io/en/company/news/lunit-to-supply-ai-platform-to-australias-breastscreen-nsw-machine-reading-project;oxy-featured-posts-card2-target:yes;oxy-featured-posts-card3-title:External evaluation of 3 commercial artificial intelligence algorithms for independent assessment of screening mammograms;oxy-featured-posts-card3-url:https://www.lunit.io/en/en/publications/external-evaluation-of-3-commercial-artificial-intelligence-algorithms-for-independent-assessment-of-screening-mammograms;oxy-featured-posts-card3-target:yes;oxy-featured-posts-card3-category:#;oxy-featured-posts-card3-date:Aug 27,2020;oxy-featured-posts-card3-image:https://lunit.io/en/wp-content/uploads/2025/09/Best_performance-3.jpg}#-lunit-benefits-section-24-107{oxy-lunit-benefits-section-cards-per-row:2;oxy-lunit-benefits-section-card-alignment:center}#-supreme-investor-section-7-107{oxy-supreme-investor-section-section-layout:content-left-image-right;oxy-supreme-investor-section-section-heading-tag:h3;oxy-supreme-investor-section-section-heading-size:f-size-xxl;padding-bottom:0px}#-supreme-investor-section-9-107{oxy-supreme-investor-section-section-layout:image-left-content-right;oxy-supreme-investor-section-secondary-buttons-count:One Button;padding-bottom:0px;oxy-supreme-investor-section-privacy-policy-link:#;oxy-supreme-investor-section-section-heading-tag:h3;oxy-supreme-investor-section-section-heading-size:f-size-xxl;padding-top:80px}#-supreme-investor-section-84-255{padding-top:80px;padding-bottom:0px}#-supreme-investor-section-78-255{padding-top:80px;padding-bottom:0px}#-supreme-investor-section-87-255{padding-top:80px;padding-bottom:80px}#-supreme-investor-section-115-2464{padding-bottom:80px;padding-top:0px}#-supreme-investor-section-120-2464{padding-top:0px}#-supreme-investor-section-30-107{oxy-supreme-investor-section-section-heading-tag:h2;oxy-supreme-investor-section-section-heading-size:f-size-4xl}@media (max-width:767px){#-supreme-investor-section-9-107{padding-top:54px}}@media (max-width:767px){#-supreme-investor-section-84-255{padding-top:54px;padding-bottom:0px}}@media (max-width:767px){#-supreme-investor-section-78-255{padding-top:54px}}@media (max-width:767px){#-supreme-investor-section-87-255{padding-top:54px;padding-bottom:0px}}@media (max-width:767px){#-supreme-investor-section-115-2464{padding-top:54px;padding-bottom:54px}}